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Abstract
Background: Endogenous nitric oxide (NO) and carbon monoxide (CO) are generated by nitric
oxide synthase and heme oxygenase, respectively. Like NO, CO has been accepted as an important
cellular signaling molecule in biological systems. An up-regulation in both gene and protein
expression of heme oxygenase-1 (HO-1) under oxidative/nitrosative stress has been well
documented, and the protective role of HO-1 and HO-2 against oxidative damage is proposed.
However, data on the direct effect of reactive oxygen/nitrogen species (ROS/RNS) on HO function
is incomplete. Using gas chromatography to quantify carbon monoxide (CO) formation from heme
oxidation, we investigated the effects of peroxynitrite (ONOO-) on the in vitro catalytic activity of
rat spleen (HO-1) and brain (HO-2) microsomal heme oxygenases.
Results: Exposure to ONOO- led to concentration-dependent but reversible decreases in the
activity of microsomal rat spleen and brain HO activity. Spleen HO activity was 100-fold more
sensitive to ONOO--dependent inactivation compared to that of the brain, with IC50 values of
0.015 ± 0.005 mM and 1.25 ± 0.25 mM respectively. Inhibition of both rat spleen and brain
microsomal HO activity was also observed with tetra-nitromethane, a tyrosine nitrating agent, as
well as two NO donors, S-nitrosoglutathione (GSNO) and diethylamine NONOate (DEA-
NONOate). However, no additive effect was found following the application of NO donors and
ONOO- together.
Conclusion: These results indicate that ONOO- may regulate HO-1 and HO-2 activities by
mechanisms that involve different interactions with these proteins. It is suggested that while
nitration of tyrosine residues and oxidation of sulfhydryl groups may be involved, consideration
should be given to other facets of ONOO- chemistry. This inhibition of HO activity offers a
mechanism for cross talk between the nitric oxide synthase and HO systems.
Background
Heme oxygenases (HO, EC 1.14.99.3) are a highly con-
served family of proteins that catalyse the oxidative cleav-
age of heme at the α-meso carbon to yield equimolar
amounts of iron, carbon monoxide (CO) and biliverdin.
Biliverdin is subsequently reduced to bilirubin by biliver-
din reductase. Three distinct isozymes of HO (HO-1, HO-
2 and HO-3) have been identified. HO-1 (the inducible
isoform) is predominantly expressed in the spleen, the
primary site of heme catabolism but has been detected in
many different tissues including the liver and the kidney.
Several substances and conditions may induce the expres-
sion of HO-1. The involvement of HO and products of
heme catabolism have been studied extensively with
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tion against transplant rejection [1-4]. HO-2 (the consti-
tutive isoform) is predominantly expressed in the testes
and the brain where HO-2 dependent CO production is
thought to aid neuronal function [5-7]. HO-3 is also a
constitutive isoform, which shares 90% homology with
HO-2 but has very limited catalytic function [8].
Increasing amounts of evidence suggest that products of
heme catabolism have cytoprotective roles such as anti-
inflammation, anti-apoptosis and anti-proliferation.
Biliverdin and bilirubin have anti-oxidant and anti-
inflammatory properties [9-11], while iron is known to
regulate transferrin, ferritin and nitric oxide synthase gene
expression [12,13]. An up regulation in the synthesis of
transferrin and ferritin enhances the binding, transport
and storage of iron thus serving as an important control
mechanism against the oxidative effects of iron. CO, like
NO, has been accepted as an important cellular signalling
molecule in biological systems. For example, both NO
and CO are known to activate soluble guanylyl cyclase,
resulting in elevated cGMP and the cGMP-mediated dila-
tation of blood vessels. CO also mediates vasodilation by
directly activating the calcium-dependent potassium
channels in vascular smooth muscle cells [14,15]. In addi-
tion, CO inhibits platelet aggregation and proliferation of
vascular smooth muscle cells, inhibits apoptosis, and
stimulates angiogenesis [16-19]. Because of the diversity
in the effects of heme catabolism, several studies have sug-
gested that induction of HO-1 expression by oxidising
agents may serve as a defense mechanism against oxida-
tive stress in vivo. For example, an induction in the expres-
sion of HO-1 prevents superoxide associated endothelial
cell sloughing in diabetic rats [20]. Similarly, it has been
demonstrated that ONOO-, a potent oxidizing agent gen-
erated by the interaction of NO and superoxide radical
[21], causes a concentration-dependent increase in HO-1
protein expression and enzyme activity in rat aortic
endothelial cells [22-24], as well as human colorectal ade-
nocarcinoma cells [25]. These studies indicate that
ONOO- regulates the expression of HO-1 and that the
heme oxygenase pathway contributes to protection
against the cytotoxic effects of ONOO- which are due to its
reactivity with cellular macromolecules such as the cova-
lent modification of tyrosine, cysteine, methionine or
tryptophan residues, oxidation of nucleic bases or the
scavenging of cellular antioxidants such ascorbate and
urate [26]. It is proposed that the ONOO--mediated HO-
1 induction might occur via an interactive signalling
mechanism that modulates oxidative stress responses but
direct effects of ONOO- on HO activity have not been
studied. In this work, we examined the effect of ONOO-
on HO catalytic activity in rat spleen and brain micro-
somes respectively.
Results
Effect of ONOO- and TNM on Microsomal HO activity
Exposure of either rat spleen or brain microsomes to
ONOO- resulted in decreases of HO activity in a concen-
tration dependent manner (Figure 1A and Figure 1B).
HO-1 (spleen microsomes) was more sensitive towards
ONOO--mediated inactivation compared to HO-2 (brain
microsomes) (Figure 1A and Figure 1B). The IC50 values
for inhibition of HO activity in rat spleen and brain
microsomes were 0.015 ± 0.005 mM and 1.25 ± 0.25 mM,
respectively. The same concentration of degraded ONOO-
did not show any effects on HO activity in rat spleen or
brain microsomal fractions. Maximal inhibition for
microsomal HO-1 and HO-2 activity was approximately
70%, beyond which there was no further inhibitory effect
with increasing concentrations of ONOO-. To investigate
whether effects of ONOO- were due to nitration of tyro-
sine residues, spleen and brain microsomal fractions were
treated with TNM, a known tyrosine-nitrating agent. It is
shown that HO activity in rat spleen as well as brain
microsomal fractions was significantly reduced by TNM
albeit at higher concentrations compared to ONOO- (Fig-
ure 2).
Effects of sulfhydryl modifying reagents on HO activity
Since ONOO- may affect protein targets by the oxidation
of sulfhydryl groups as well as the nitration of tyrosine res-
idues, we examined and compared the effect of other sulf-
hydryl modifying reagents on HO activity. Rat spleen or
brain microsomal protein was treated with different sulf-
hydryl modifying reagents such as GSNO, DEA-NON-
Oate, NEM and H2O2, and a combination of equimolar
concentrations of ONOO- and GSNO or ONOO- and
DEA-NONOate. We found that GSNO caused a concen-
tration dependent inactivation of both HO-1 and HO-2.
Consistent with the effect of ONOO-, GSNO was more
active against HO-1 than HO-2 (Table 1). In contrast,
DEA-NONOate and NEM caused a significant decrease in
the catalytic activity of HO-1 at the two concentrations
tested (0.2 mM and 2 mM), but did not inhibit HO-2
(Table 1). Pre-treatment with equimolar concentrations
of ONOO- and DEA-NONOate or GSNO did not result in
further inactivation of HO-1 or HO-2 than ONOO- alone.
H2O2 at concentrations as high as 2 mM had no signifi-
cant effect on the catalytic activity of either isozymes.
To test whether effects of ONOO- and the sulfhydryl mod-
ifying reagents on HO-1 and HO-2 are reversible, ONOO-
and DEA-NONOate were pre-incubated with rat spleen
and brain microsomal protein for 20, 60 and 120 minutes
prior to evaluation of HO activity. The inactivation of HO-
1 by ONOO- and DEA-NONOate and HO-2 by ONOO-
was reversible following prolonged pre-incubation time
(60–120 minutes) Table 2. However, total HO activity inPage 2 of 9
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ONOO--mediated inactivation of HO-1 and HO-2. Rat spleen (Figure 1A) and brain microsomes (Figure 1B) (50–100 µg 
protein) were treated with indicated concentrations of ONOO- or degraded ONOO- in 100 mM potassium phosphate, pH 7.4 
at room temperature for 10 seconds. The reaction was stopped by dilution of the reaction mixture to a protein concentration 
of (0.5 mg/mL) spleen microsomes and (1 mg/mL) brain microsomes in 100 mM phosphate buffer containing 1 mM NADPH 
and 50 µM methemalbumin. Incubations of the pretreated microsomal fractions were performed for 15 min and enzyme activ-
ity was determined by the quantitation of CO formed in the reaction mixture. Data are presented as the mean ± SD of tripli-
cate experiments. The rates of CO formation in the control reactions were 12 ± 1 and 5 ± 1 pmoles CO/min/mg protein for 
spleen and brain microsomes respectively. IC50 values for HO-1 and HO-2 were 0.015 ± 0.005 mM and 1.25 ± 0.25 mM 
respectively.
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the prolonged pre-incubation for 60–120 minutes in the
absence of ONOO- and DEA-NONOate.
Discussion
Production of ONOO- in vivo is a consequence of oxida-
tive and nitrosative stress, and ONOO--mediated tissue
injury is thought to be involved in the pathogenesis of
many conditions including atherosclerosis, ischaemia/
reperfusion, shock, Alzheimer's disease, diabetes and
multiple sclerosis [27-30]. Continuous challenge and
exposure to oxidative/nitrosative stressors has led to the
evolution of numerous defense mechanisms in biological
systems and one such mechanism that has been eluci-
dated by many researchers is the HO/CO system [4,9-11].
ONOO- causes a concentration-dependent increase in
Effect of TNM-mediated nitration on the catalytic activity of HOFigure 2
Effect of TNM-mediated nitration on the catalytic activity of HO. HO-1 (rat spleen microsomes and HO-2 (rat brain 
microsomes). Microsomal protein (50–100 µg) was incubated with 0.2 mM or 2 mM (final concentration) of TNM in 100 mM 
potassium phosphate buffer, pH 7.4, at 37°C for 20 minutes. The reaction was stopped by dilution of the reaction mixture to a 
protein concentration of (0.5 mg/mL) in 100 mM phosphate buffer containing 1 mM NADPH and 50 µM methemalbumin. Incu-
bations of the pretreated microsomal protein were done for 15 min and enzyme activity was determined by the quantitation of 
CO formed in the reaction mixture. Data are presented as the mean ± SD of triplicate experiments. The rate of CO formation 
in control reactions was 11.4 ± 0.6 and 4.0 ± 0.14 pmoles CO/min/mg protein for HO-1 and HO-2 respectively. The asterisk 
denotes significant inhibition of the respective HO activity using a one-way ANOVA, P ≤ 0.05.
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contributes to protection against the cytotoxic effects of
ONOO- [22-24]. Most studies in this field, however, have
focussed on the induction of HO-1 mRNA and/or protein
expression under different conditions of oxidative/nitro-
sative stress rather than enzyme activity. Considering the
cellular toxicity of ONOO- and the inhibitory effect of
ONOO- on numerous enzyme systems, we sought to
investigate the direct effect of ONOO- on the catalytic
activity of two microsomal HO isozymes.
Rat spleen and brain microsomal fractions were used
because of the predominant expression of HO-1 in the
spleen and HO-2 in the brain. We have shown that
ONOO- inhibits the activity of both HO-1 and HO-2 in a
concentration-dependent manner (Figure 1). HO-1 was
found to be more sensitive to ONOO- treatment com-
pared to HO-2. Lower concentrations of ONOO- (15 µM,
final concentration) decreased HO-1 activity by 50%
while a much higher concentration (1.25 mM) was
required to decrease HO-2 activity by the same magni-
tude. Generally, HO catalytic function is dependent on an
accessory enzyme NADPH-cytochrome P450 reductase
(CPR), which serves as a redox partner during the oxida-
tive break down of heme and the conversion of NADPH
to NADP+. It is possible therefore, that ONOO- may have
altered HO activity indirectly by inactivating CPR. The
ONOO- dependent inactivation of recombinant CPR in
bacterial membranes has been noted [32], but our
attempt to supplement rat microsomal HO-1 and HO-2
with recombinant rat CPR in the presence of a detergent
did not attenuate the effect of ONOO- on microsomal
HO-1 and HO-2 (data not shown). This suggests that the
effects of ONOO- on HO activity may be mediated by
mechanisms that are independent of the effect of ONOO-
on microsomal CPR activity. The differential effect of
ONOO- on the catalytic activity of HO-1 and HO-2 may
suggest a selective mechanism on the catalytic function of
the inducible enzyme. This may have direct implications
in biological systems where ONOO- is generated at high
concentrations. The ONOO--mediated increase in HO-1
gene and/or protein expression may be a cellular response
Table 1: Effect of NO donors and sulfhydryl modifying reagents on the catalytic activity of HO-1 (spleen microsomes) and HO-2 (brain 
microsomes)
Heme oxygenase activity (pmoles CO/min/mg protein)
Experimental conditions HO-1 (Spleen microsomes) HO-2 (Brain microsomes)
Control 11.9 ± 0.6 3.1 ± 0.5
ONOO-
0.2 mM 5.4 ± 0.9* 2.7 ± 0.6
2 mM 3.8 ± 0.9* 1.4 ± 0.3*
GSNO
0.2 mM 6.5 ± 0.3* 2.9 ± 0.5
2 mM 4.2 ± 0.2* 1.4 ± 0.1*
DEA-NONOate
0.2 mM 4.7 ± 0.4* 2.9 ± 0.7
2 mM 3.6 ± 0.4* 2.4 ± 0.5
NEM
0.2 mM 8.7 ± 0.8 2.9 ± 0.3
2 mM 3.4 ± 0.5* 2.6 ± 0.4
H2O2
0.2 mM 11.3 ± 0.2 3.0 ± 0.4
2 mM 11.8 ± 1.5 3.2 ± 0.6
ONOO- and GSNO
0.2 mM 4.3 ± 0.6* 2.8 ± 0.4
2 mM 4.0 ± 0.2* 1.3 ± 0.2*
(ONOO- and DEA-NONOate)
0.2 mM 4.7 ± 0.1* 2.6 ± 0.2
2 mM 3.9 ± 0.6* 1.4 ± 0.3*
Microsomal protein (50–100 µg) was incubated with 0.2 mM or 2 mM (final concentration) of ONOO-, GSNO, DEA-NONOate, NEM, H2O2, 
equimolar concentrations of ONOO- and GSNO or ONOO- and DEA-NONOate in 100 mM potassium phosphate buffer, pH 7.4, at 37°C for 20 
minutes. The reaction was stopped by dilution of the reaction mixture to a protein concentration of (0.5 mg/mL) in 100 mM phosphate buffer 
containing 1 mM NADPH and 50 µM methemalbumin. Incubations of the pretreated microsomal fractions were done for 15 min and enzyme 
activity was determined by the quantitation of CO formed in the reaction mixture. Data are presented as the mean ± SD of triplicate experiments. 
Asterisks denote significant inhibition of the respective HO activity using a one-way ANOVA, P ≤ 0.05.Page 5 of 9
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then be maintained in certain ranges in order to retain
intracellular oxidative responses and the balance of redox
states for normal cellular function. This idea is consistent
with other studies, which have shown that induction of
HO-1 mRNA and protein expression is not always fol-
lowed by a proportionate increase in catalytic function.
For example, by using quantitative RT-PCR it was found
that a 3.8-fold increase in sarcoma-induced HO-1 mRNA
expression yields only 2.1-fold increase in total HO activ-
ity [31]. Overall, the ONOO--mediated regulation of the
catalytic function of HO-1 and differences in the sensitiv-
ity of HO-1 and HO-2 may be attributed to disparity in
the amino acid compositions and the structure of the two
proteins.
Mechanistically, the effects of ONOO- on protein function
are mainly due to its reactivity and covalent modification
of tyrosine and/or cysteine residues [26]. This often leads
to impaired protein function with very few exceptions
such as the recently observed nitration and stimulation of
the enzymatic activity of microsomal glutathione S-trans-
ferase (MGST) [33]. To probe mechanisms of ONOO--
mediated inhibition of HO activity observed here, we
examined the effects of TNM, another tyrosine-nitrating
chemical compound on rat spleen and brain microsomal
HO activity. Significant inhibition of HO catalytic activity
by TNM was observed for spleen as well as brain micro-
somal fractions albeit at higher concentrations compared
to ONOO- (Figure 2). This suggests that both TNM and
ONOO- may inactivate HO activity by nitration of tyro-
sine residue(s) that is/are important for conservation of
HO-1 and HO-2 function. This is consistent with data
from the analysis of the complete amino acid sequences of
rat and human HO-1 [34,35] and HO-2 [36,37]. How-
ever, there was no difference in the effects of TNM on HO-
1 and HO-2 (Figure 2), suggesting that the differential
effects observed with ONOO- could be due to modifica-
tion of amino acid residues other than tyrosine. Oxidation
of cysteine residues as a putative mechanism underlying
ONOO--mediated inactivation of HO was investigated.
Effects of GSNO, DEA-NONOate, NEM and H2O2, or a
combination of equimolar concentrations of ONOO- and
GSNO or DEA-NONOate on HO activity were tested.
GSNO showed similar inhibitory effects to ONOO- but a
combination of equimolar concentrations of ONOO- and
DEA-NONOate or GSNO did not have any additive effect
on the ONOO--mediated inactivation of HO-1 or HO-2.
In addition, the inactivation of HO-1 by ONOO- and
DEA-NONOate and HO-2 by ONOO- were reversible fol-
lowing prolonged pre-incubation time (60–120 minutes)
Table 2. This differential effect between HO-1 and HO-2
following exposure to ONOO-, GSNO, DEA-NONOate or
NEM is suggestive of qualitative as well as quantitative dif-
ferences in the distribution of target amino acids such as
critical tyrosine and/or cysteine residues in the tertiary
structures of these proteins. The amino acid sequences of
human and rat HO-2 reveals a conserved core of cysteine
residues (Cys 264-Pro 265, Cys 281-Pro 282) [38,39], but
there are no cysteine residues in the HO-1 amino acid
sequence. Despite this fact, results from our experiments
show that HO-1 is more sensitive to inactivation by the
NO donors GSNO and DEA-NONOate, and NEM (Table
1). We considered the possibility that ONOO- might exert
its effects by interaction with the substrate as has been
reported for the interaction of NO with heme [40]. This
possibility seems unlikely as such a mechanism would be
expected to affect the catalytic rate of HO-1 and HO-2
equally. Another consideration is that the chemistry of
ONOO- is richer than is usually discussed; in their review
Alvarez and Radi [41] describe the interactions of ONOO-
with a number of functional groups that are not often
mentioned in the consideration of the interactions of
ONOO- with various proteins. Thus, ONOO- inhibition of
HO activity could be a result of an interaction with amino
acids other than cysteine or tyrosine. This possibility of
ONOO- interactions with other amino acids may also
explain the reversibility of the inhibition of HO activity by
ONOO-. Furthermore, it is possible that ONOO- inhibi-
tion of HO-1 and HO-2 occurs courtesy of different facets
of ONOO- chemistry. Differences in the relative potency
of DEA-NONOate, NEM, GSNO and ONOO- may also be
attributed to differences in the chemical properties and
the electrophilic potentials of these reagents. For instance,
the nitric oxide radical (NO•) generated from DEA-NON-
Oate is less reactive and unstable compared to NO+ pro-
duced from GSNO.
Collectively, our data indicate that ONOO- may be impor-
tant in the cross-talk between HO and NO systems. While
tyrosine residues for HO-1 and/or sulfhydryl groups for
HO-2 should be considered as potential targets for
ONOO- interactions, other amino acids should be studied
in the elucidation of mechanism(s) of ONOO- action on
HO isozymes.
Conclusion
This study documented for the first time the ONOO--
mediated inactivation of HO-1 and HO-2. The IC50 for
HO-1 was approximately 80-fold less than that for HO-2.
While conserved tyrosine residues (HO-1) and/or sulfhy-
dryl group(s) (HO-2) may play a critical role in maintain-
ing the functional capacity of heme oxygenases, the
consideration of other amino acids is suggested. In addi-
tion, the higher sensitivity of HO-1 to ONOO--mediated
inactivation may indicate dual regulatory mechanisms on
the catalytic function of the inducible enzyme under the
conditions of oxidative/nitrosative stress.Page 6 of 9
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Materials
Hemin, ethanolamine, bovine serum albumin (BSA), β-
NADPH, N-ethylmaleimide (NEM), tetra-nitromethane
(TNM) and reduced glutathione (GSH) were purchased
from Sigma Chemical Co. (St. Louis Mo.). Diethylamine
NONOate (DEA-NONOate) was obtained from Calbio-
chem Inc. (Darmstadt, Germany). All other chemicals
were reagent grade from a variety of commercial sources.
Preparation of rat spleen and brain microsomes
Adult male Sprague-Dawley rats (250–300 g) were
obtained from Charles River Canada Inc. (St-Constant,
Que). The animals were cared for in accordance with the
principles and guidelines of the Canadian Council on
Animal Care. Microsomal fractions were prepared accord-
ing to previously described procedures [42,43]. Spleen
microsomes were used as a source of HO-1 while brain
microsomes were used as a source of HO-2.
Preparation of ONOO- and treatment of microsomal 
protein
ONOO- was synthesised from acidified nitrite and H2O2
according to the method of Beckman [44] and micro-
somal HO-1 (spleen microsomes) and HO-2 (brain
microsomes) were treated with ONOO- following the pro-
cedures described by Ji and Bennett [33]. Briefly, micro-
somes (50 –100 µg protein in 100 mM potassium
phosphate, pH 7.4) were exposed to ONOO- at room tem-
perature at indicated concentrations for 10 seconds by
adding a small volume during vigorous mixing. HO activ-
ity was initiated by diluting the reaction mixture to a pro-
tein concentration of (0.5–1 mg/ml) in 100 mM
phosphate buffer containing substrates (50 µM
methemalbumin, and 1 mM NADPH). To control for the
potential effect of nitrite and nitrate that may be formed
during the incubation of ONOO-, ONOO- was allowed to
decompose in phosphate buffer prior to incubation with
microsomal protein and determination of enzyme activity
for some of the reactions.
Treatment of microsomes with NO donors, TNM and 
sulfhydryl modifying reagents
GSNO was prepared by reacting equimolar amounts of
sodium nitrite and GSH according to the method
described by Ji et al., [43]. Microsomal protein (50 – 100
µg) was incubated with 0.2–2 mM GSNO, DEA-NON-
Oate, NEM or H2O2 in 100 mM potassium phosphate
buffer, pH 7.4, at 37°C for 20 minutes. The reaction was
stopped by dilution of the reaction mixture to a protein
concentration of (0.5–1 mg/mL) in 100 mM phosphate
buffer containing (50 µM methemalbumin, and 1 mM
NADPH).
In vitro Assay for HO activity
HO activity in rat spleen and brain microsomal fractions
was determined by the quantitation of CO formed from
the oxygen, CPR and NADPH-dependent degradation of
methemalbumin as previously described [45,46]. The
reaction mixture contained, (0.5–1 mg/mL microsomal
Table 2: Time dependent reversibility of the effect of ONOO- and DEA-NONOate on the catalytic activity of HO-1 (spleen microsomes) 
and HO-2 (brain microsomes)
Heme oxygenase activity (pmoles CO/min/mg protein) at different pre-
incubation times
Experimental conditions 20 min 60 min 120 min
Spleen microsomes (HO-1) ONOO-
Control 10.4 ± 1.0 10.8 ± 0.8 8.7 ± 0.9
0.2 mM 3.6 ± 1.4* 10.5 ± 0.8 8.3 ± 1.1
DEA-NONOate
Control 10.6 ± 2.0 11.5 ± 1.3 9.4 ± 0.2
0.2 mM 6.6 ± 0.7* 11.1 ± 1.4 8.9 ± 0.3
Brain microsomes (HO-2) ONOO-
Control 3.6 ± 0.5 4.2 ± 0.4 4.4 ± 0.3
2 mM 1.9 ± 0.1* 4.4 ± 0.3 3.8 ± 0.3
DEA-NONOate
Control 3.6 ± 0.3 4.1 ± 0.3 4.0 ± 0.3
2 mM 3.0 ± 0.3 3.9 ± 0.1 3.6 ± 0.3
Microsomal protein (50–100 µg) was incubated with 0.2 mM or 2 mM (final concentration) of ONOO- and DEA-NONOate in 100 mM potassium 
phosphate buffer, pH 7.4, at 37°C for 20, 60 and 120 minutes. The reaction was stopped by dilution of the reaction mixture to a protein 
concentration of (0.5 mg/mL) in 100 mM phosphate buffer containing 1 mM NADPH and 50 µM methemalbumin. Incubations of the pretreated 
microsomal fractions were done as described in materials and methods. Data are presented as the mean ± SD of triplicate experiments. Asterisks 
denote significant inhibition of the respective HO activity using a one-way ANOVA, P ≤ 0.05.Page 7 of 9
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100 mM phosphate buffer. All incubations for the assay of
HO activity were performed under the conditions for
which the rate of CO formation (pmol CO. mg-1 protein.
min-1) was linear with respect time and microsomal pro-
tein concentration. CO formation was monitored by gas
chromatography according to the method described by
Vreman and Stevenson [46].
Statistical analysis
Data are presented as the mean ± SD from triplicate exper-
iments and statistical analyses were performed by one-
way ANOVA. P values ≤ 0.05 was considered to be
significant.
Abbreviations
HO, heme oxygenases; CPR, NADPH-cytochrome P450
reductase; CO, carbon monoxide; ONOO-, peroxynitrite;
GSNO, S-nitrosoglutathione; DEA-NONOate, diethyl-
amine NONOate; NEM, N-ethylmaleimide; TNM, tetra-
nitromethane; ROS/RNS, reactive oxygen/nitrogen spe-
cies; RT-PCR; reverse transcriptase polymerase chain reac-
tion;  H2O2, hydrogen peroxide.
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